Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Sergei Doulatov
Leukemias
Randall Davis
CLL
Ravi Bhatia
transplantation
John Crispino
myelofibrosis, pediatric leukemia and Downs
Bingyi Chen
AML immunotherapy
Jaehyuk Choi
T-cell lymphoma
Jonas Jutzi
myeloproliferative neoplasms
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Coleman Lindsley
AML/MDS
Margaret Shipp
lymphoma biology
Julia Maxson
AML
Faron Pharmaceuticals
immunotherapy, MDS
Catherine Smith
leukemia
Mark Murakami
follicular lymphoma
Jonathon Cohen
lymphoma clinical trial access in Georgia
Constellation Pharmaceuticals
myeloproliferative neoplasms
Robert Orlowski
(Smoldering) Multiple Myeloma
Gaurav Goyal
Erdheim-Chester Disease
Jeetayu Biswas
splicing in myeloid diseases
Yoke Seng Lee
AML
Madhav Dhodapkar
multiple myeloma immunotherapy
Qing Yi
Novel CAR-T
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Kura Oncology
MLL leukemia, AML
Manyi Wei
acute megakaryoblastic leukemia
Soheil Meshinchi
pediatric AML
Daniel Herranz
T-ALL
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Riccardo Dalla-Favera
lymphoma (DLBCL)
Courtney Jones
AML metabolism
Jenny Wang
AML
Eugenio Morelli
Myeloma
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Jing Yang
Myeloma
Christian Steidl
B-cell lymphomas
Ann-Kathrin Eisfeld
Racial diversity in AML
Eric Padron
CMML
Simona Colla
Myeloma biology
Hong Wen
AML
Rajni Kumari
AML
Ravindra Majeti
preleukemia, AML
Ana Vujovic
AML
Adam de Smith
pediatric ALL and Down Syndrome
Catherine Diefenbach
DLBCL immunology
Dimericon Therapeutics
dimericons, blood cancer
Mark Dawson
B-ALL and CAR-T resistance
Adam Olszewski
Follicular and marginal zone lymphoma
ImCheck Therapeutics
immunotherapy, AML
Daniel Lucas
bone marrow and leukemia biology
Joachim Yahalom
Lymphoma
Britta Will
Leukemia and pre-leukemia
Teresa Palomero
Peripheral T-cell Lymphoma
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Leandro Cerchietti
DLBCL
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Adi Nagler
Bronchiolitis obliterans after transplant
Wendy Stock
T-cell ALL
Tomasz Skorski
myeloproliferative neoplasms, AML
Michael Kharas
leukemia
Mark Hamilton
DLBCL and CAR-T
Nirav Shah
CAR-T for lymphoma
Armin Rashidi
gut bacteria and transplant success
Jennifer Amengual
lymphomas after transplant
Keisuke Ito
blood cancer stem cells and MDS metabolism
George Vassiliou
Leukemia Prevention
Eric Pietras
AML
George Daley
"off-the-shelf" CAR-T and CAR-NK
Roland Walter
Antibody-based AML therapies
Kasey Leger
pediatric blood cancers
Kathleen Sakamoto
pediatric AML
Trent Hall
MDS
Raymond Mailhot
Equity in Access
Sham Mailankody
Myeloma immunotherapy clinical trials
Paolo Caimi
CAR-T clinical trial for CLL
Enterome
vaccine, FL, MZL
Christian Marinaccio
MLL leukemias
Bing Carter
p53 mutant AML
Brian Dalton
DNA mutations and myeloid cancers
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Inhye Ahn
CLL
Neha Mehta-Shah
T-cell lymphoma
Maximilian Stahl
AML immunotherapy
Kirk Schultz
pediatric transplantation
Urvi Shah
Diet and myeloma
Nitin Jain
CLL
Jake Shortt
precision therapy for aggressive lymphomas
Takeshi Sugio
T-cell lymphoma
Fenghuang Zhan
Myeloma and bone disease
Gianpietro Dotti
CAR T and AML
Stacie Dusetzina
Equity in Access
Courtney DiNardo
clinical trials, AML
John Leonard
lymphoma research
Eirini Papapetrou
blood cancer stem cells
Tanya Siddiqi
clinical trial access
Nicoletta Cieri
AML and transplantation
Enrico Tiacci
Hairy cell leukemia
Marina Konopleva
MDS/AML metabolism
Bailee Kain
AML and African ancestry
Oreofe Odejide
Equity in Access
Jeremy Baeten
AML
Matteo Bellone
Smoldering multiple myeloma
Tak Mak
Immunotherapy
Jennifer Trowbridge
aging and leukemia
Daniel Pollyea
AML
Mendel Goldfinger
MDS/AML trials for the elderly
Taishi Yonezawa
AML
Affimed
immunotherapy, HL, PTCL
Peter Klein
MDS
Suman Paul
T cell cancers and immunotherapy
Michael Savona
MDS and leukemia
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Caroline Arber
myeloma CAR-T
Alexey Danilov
lymphoma
Lev Kats
myeloma and epigenetics
Mala Shanmugam
myeloma
Jianguo Tao
Mantle Cell Lymphoma
Martin Dreyling
Mantle Cell Lymphoma
Carma Bylund
Equity in Access
Steven Horwitz
T-cell lymphomas
Yibin Yang
Lymphoma
Noemí Puig Morón
Myeloma
Caner Saygin
T-ALL
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Wendy Béguelin
follicular lymphoma
Carl Allen
pediatric blood cancers
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Amit Verma
AML/MDS
Michael Green
lymphoma biology
Anushree Vichare
Equity in Access
Jianhua Yu
myeloma immunotherapy
Catriona Jamieson
cancer stem cell biology
Jeffrey Magee
pediatric AML
Kimberly Stegmaier
childhood blood cancers
Brian Walker
smoldering myeloma, MGUS
Dan Landau
cancer evolution biology
Jing Fu
myeloma
Rachel Mersfelder
AMKL
Richard Lock
T-ALL
Pietro Genovese
transplant and AML
Peter Croucher
Multiple Myeloma
Liran Shlush
pre-leukemia
Steven Treon
Lymphomas and Waldenstrom's
Venkata Lokesh Battula
immunotherapy and AML
Logan Spector
childhood leukemia epidimiology
Anouchka Laurent
T-cell lymphoma
Daniel Thomas
Myelofibrosis
Sarah Tasian
pediatric leukemias
Justine Kahn
pediatric leukemia and lymphoma
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Siegfried Janz
Myeloma immunotherapy
Liling Wan
AML
Koichi Takahashi
AML/MDS
Alieen Rowan
Adult T cell leukemia/lymphoma
Christopher Flowers
clinical trial access
Sigurður Kristinsson
Smoldering myeloma
Frederick Locke
lymphoma and immunotherapy
Marco Ruella
Immunotherapy for T-cell lymphoma
Daisuke Nakada
preleukemia, leukemia
Philippe Armand
follicular lymphoma
Ari Melnick
epigenetics and lymphoma
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Sheng Li
Aging and AML
Alex Kentsis
pediatric leukemias
Solu Therapeutics
immunotherapy, CMML
H. Irene Su
Equity in Access
Hao Jiang
DNA biology and leukemia
Pooja Khandelwal
bone marrow transplantation
Lucy Godley
preleukemia
Carl June
CAR T immunotherapy
Yubin Zhou
peripheral T cell lymphoma
Timothy Graubert
AML and MDS biology
Jennifer Woyach
CLL trials
Lindsey Montefiori
pediatric leukemia
Qingyu Luo
BPDCN
Thomas Kipps
Hairy Cell Leukemia
Kerry Rogers
CLL
Ronald Levy
immunotherapies, COVID-19
Julia Paczkowska
immunobiology of Hodgkin's disease
Michael Keller
COVID-19, immunotherapy
Omar Abdel-Wahab
Hairy cell leukemia
Robert Soiffer
transplantation
Alfred Garfall
myeloma immunotherapy
Suzanne Lentzsch
Myeloma
Matthew Frank
Lymphoma CART therapy
BioInvent International
immunotherapy, indolent NHL, CTCL
Thomas LeBlanc
palliative care
Tyler Parsons
MPN and AML
Siddhartha Jaiswal
preleukemia
James Rubenstein
Lymphoma of the Central Nervous System
Steven Park
follicular lymphoma
Helen Parsons
Equity in Access
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
F. Lennie Wong
Equity in Access
Jessica Stewart
Epstein-barr virus and lymphomas
Sriram Sundaravel
AML stem cells
Paolo Strati
Non-Hodgkin Lymphoma
Shazia Nakhoda
Equity in Access
Roberta Zappasodi
lymphoma, immunotherapy
Rong Lu
preleukemia, leukemia
Luca Busino
DLBCL
Yiman Liu
Epigenetics and leukemia
Jolanta Grembecka
leukemia therapeutics
Catherine Bollard
pediatric blood cancers and immunotherapy
Lori Muffly
Equity in Access
Jean Koff
Disparities in DLBCL
Rizwan Romee
Immunotherapy
Jayna Mistry
aging and leukemias
Ruben Carrasco
Myeloma
Tycel Phillips
Mantle Cell Lymphoma
Michaela Reagan
Multiple Myeloma
William Matsui
Myeloma
Sahand Hormoz
MPN
Jun Qi
Myeloma
Craig Jordan
AML
Xu Ji
Equity in Access
Ricky Johnstone
lymphoma and myeloma
Srividya Swaminathan
pediatric, immunotherapy
Marc Seifert
Hairy cell leukemia
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Thomas Koehnke
leukemia
Dane Vassiliadis
blood cancer biology
Huda Salman
CMML
Jalpa Doshi
Equity in Access
Anthony Letai
improving CAR-T
Markus Muschen
leukemia and lymphoma biology
Christopher Porter
Leukemia, lymphoma
Saar Gill
AML immunotherapy
Jonathan Licht
DNA biology, myeloma
Nizar Bahlis
Myeloma immunotherapy
Christopher Booth
BPDCN
Caron Jacobson
lymphoma and immunotherapy
Nicola Vannini
Aging and CAR-T success
Andrew Lane
BPDCN
Nataly Cruz-Rodriguez
T-ALL and metabolism
Michael Wang
Mantle Cell Lymphoma
Shannon Maude
Immunotherapy for ALL
Elliot Stieglitz
CMML
Reina Takeda
AML
Grzegorz Nowakowski
Clinical trial access
Yan Liu
MDS
Megan McNerney
AML/MDS
Cailin Collins
Leukemia and pre-leukemia
Rgenta Therapeutics
RNA-targeting, blood cancer
Fahmin Basher
transplant and GvHD
Meng Li
Equity in Access
Nicolas Nassar
pediatric leukemia
Christine Zhang
AML
Sam Butterworth
CMML
Paul Beavis
immunotherapy in myeloma
Lawrence Boise
CART and myeloma
Stephen Gottschalk
pediatric leukemia and CAR-T
Bruno Paiva
smoldering myeloma
John DiPersio
trispecific antibody for AML and MDS
Grant Challen
preleukemia, leukemia
Paola Aguilar Neuville
Primary cutaneous γδ T-cell lymphoma
Stephen Nimer
myeloid cancer biology
Piers Patten
COVID-19